Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
BMI greater than 30 kg/m2
History of at least 1 self-reported unsuccessful dietary effort to reduce body weight
You may not be if
Change in body weight of greater than 5 kg (11 pounds) within 3 months prior to start of study
Any of the following treatments for obesity within 1 year prior, or plan to undergo any of these during the study period: liposuction, cryolipolysis, or abdominoplasty
Prior or planned bariatric or gastric sleeve surgery, endoscopic therapy, or device-based therapy for obesity
Type 1 or Type 2 Diabetes, history of ketoacidosis, or hyperosmolar state
Family or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome Type 2
Acute or chronic hepatitis
Had within 90 days prior: acute myocardial infarction, cerebrovascular accident (stroke), coronary artery revascularization, hospitalization for unstable angina, or hospitalization due to congestive heart failure
History of active or unstable major depressive disorder or other severe psychiatric disorder within 2 years prior
History of chronic or acute pancreatitis
Blood transfusion or severe blood loss within the last 3 months or hemoglobinopathy, hemolytic anemia, sickle cell anemia
Clinically significant multiple or severe drug allergies
Started treatment with or changed dose within 12 months prior any medications that are associated with significant weight gain
History of substance use disorder
Clareo Health | A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
